Abstract
Ischemic heart disease is among the leading causes of death in the United States (1), and one of the most frequently treated diseases in US Department of Veterans Affairs (VA) health care facilities. Each year, VA facilities provide more than 150,000 hospital stays for patients with this condition, including some 15,000 stays for myocardial infarction (MI) and some 23,000 stays for unstable angina (2). As part of its mission, VA conducts clinical trials to improve the quality and effectiveness of patient care, including several trials examining strategies for treating ischemic heart disease. Cost-effectiveness (CE) is an increasingly important part of these studies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Centers for Disease Control. Chronic Diseases and Their Risk Factors: The Nation’s Leading Causes of Death. US Department of Health and Human Services, Atlanta, GA, 1999.
Every NR, Fihn SD, Sales AE, et al. Quality Enhancement Research Initiative in ischemic heart disease: a quality initiative from the Department of Veterans Affairs. QUERI IHD Executive Committee. Med Care 2000; 38 (6 Suppl 1): I49 — I59.
Barnett P. Review of methods to determine VA health care costs. Med Care 1999;37:AS9—AS17.
Swindle R, VanDeusen-Lukas C, Alexander-Meyer D, et al. Cost analysis in the Department of Veterans Affairs: Consensus and future directions. Med Care 1999;37:AS3—AS8.
Barnett PG, Chen S, Boden W, et al. Cost-effectiveness of conservative management of non Q-wave myocardial infarction. Circulation 2002, 105: 680–684.
Miller ME, Welch WP. Analysis of Hospital Medical Staff Volume Performance Standards: Technical Report. The Urban Institute, Washington DC, 1993.
Barnett PG, Rodgers JH. Use of the decision support system for VA cost-effectiveness research. Med Care 1999;37:AS63—AS70.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613–619.
Peterson K, Swindle R, Phibbs C, et al. Determinants of re-admission following inpatient substance abuse treatment: a national study of VA programs. Med Care 1994; 32: 535–550.
Weintraub WS, Craver JM, Jones EL, et al. Improving cost and outcome of coronary surgery. Circulation 1998; 98 (19 Suppl): 1123–1128.
Petersen LA, Normand SL, Daley J, McNeil BJ. Outcome of myocardial infarction in Veterans Health Administration patients as compared with medicare patients. N Eng J Med 2000; 343: 1934–1941.
Chen J, Radford MJ, Wang Y, et al. Performance of the “100 top hospitals”: what does the report card report? Health Aff 1999; 18: 53–68.
MaWhinney S, Brown ER, Malcolm J, et al. Identification of risk factors for increased cost, charges, and length of stay for cardiac patients. Ann Thorac Surg 2000; 70: 702–710.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Barnett, P.G., Lin, P., Wagner, T.H. (2003). Estimating the Costs of Cardiac Care Provided by the Hospitals of the US Department of Veterans Affairs. In: Weintraub, W.S. (eds) Cardiovascular Health Care Economics. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-398-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-59259-398-9_2
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9784-7
Online ISBN: 978-1-59259-398-9
eBook Packages: Springer Book Archive